Your browser doesn't support javascript.
loading
Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology.
Telford, Bryony J; Yahyanejad, Sanaz; de Gunst, Thijs; den Boer, Harm C; Vos, Rogier M; Stegink, Marieke; van den Bosch, Marion T J; Alemdehy, Mir Farshid; van Pinxteren, Laurens A H; Schaapveld, Roel Q J; Janicot, Michel.
Affiliation
  • Telford BJ; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Yahyanejad S; InteRNA Technologies BV, Utrecht, The Netherlands.
  • de Gunst T; InteRNA Technologies BV, Utrecht, The Netherlands.
  • den Boer HC; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Vos RM; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Stegink M; InteRNA Technologies BV, Utrecht, The Netherlands.
  • van den Bosch MTJ; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Alemdehy MF; InteRNA Technologies BV, Utrecht, The Netherlands.
  • van Pinxteren LAH; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Schaapveld RQJ; InteRNA Technologies BV, Utrecht, The Netherlands.
  • Janicot M; InteRNA Technologies BV, Utrecht, The Netherlands.
Oncotarget ; 12(5): 422-439, 2021 Mar 02.
Article in En | MEDLINE | ID: mdl-33747358

Full text: 1 Database: MEDLINE Language: En Journal: Oncotarget Year: 2021 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Language: En Journal: Oncotarget Year: 2021 Type: Article Affiliation country: Netherlands